首页 › 基金 › Artia Global Partners LP › CMPX

Artia Global Partners LP 对 CMPX 的持仓历史

COMPASS THERAPEUTICS INC · 医疗保健

Artia Global Partners LP 在 Q2 2026 的 13F 申报中披露持有 CMPX(COMPASS THERAPEUTICS INC)383,200 股,市值约 US$839K,约占其申报组合的 0.15%,在其申报持仓中市值排名第 42 位。 Artia Global Partners LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)383.20K 股
申报持仓市值$839.21K
组合权重0.15%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Artia Global Partners LP 对 CMPX 的持仓演变

Artia Global Partners LP 于 Q2 2026 首次披露 CMPX 持仓:383,200 股(约 US$839K)。

逐季持仓明细

季度股数金额变化
Q2 2026 383.20K $839.21K 新进

关于 CMPX 与 13F 数据

CMPX(COMPASS THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 CMPX,申报仓位最大的包括:TANG CAPITAL MANAGEMENT LLC (US$39.4M), ORBIMED ADVISORS LLC (US$33.3M), MONTANOVA CAPITAL, LLC (US$30.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CMPX 的基金

查看 CMPX 的全部基金持有人 →

常见问题

How long has Artia Global Partners LP held CMPX?

Artia Global Partners LP has disclosed CMPX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Artia Global Partners LP's current position in CMPX?

As of Q2 2026, Artia Global Partners LP holds 383.20K shares of CMPX (COMPASS THERAPEUTICS INC), valued at $839.21K, representing 0.15% of its reported portfolio and ranking #42.

Has Artia Global Partners LP been buying or selling CMPX?

In the latest 13F filing (Q2 2026), Artia Global Partners LP newly opened its position in CMPX.

Which other funds hold CMPX?

Other major institutional holders of CMPX include TANG CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, MONTANOVA CAPITAL, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.